Stocktoria

REVVITY, INC. RVTY

NYSE · stock · Laboratory Analytical Instruments · website · IPO 1965-07-06 · LEI

REVVITY, INC. financials (annual)

Revenue
$2.12B $2.26B $2.78B $2.88B $3.78B $3.83B $3.31B $2.75B $2.76B $2.86B 2017201720182019202120222023202320242025
Net income
$234.3M $292.6M $237.9M $227.6M $727.9M $943.2M $569.2M $693.1M $270.4M $241.2M 2017201720182019202120222023202320242025
Free cash flow
$318.9M $253.1M $218.0M $287.1M $828.5M $1.32B $594.2M $198.0M $578.3M $515.4M 2017201720182019202120222023202320242025

Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2023FY2022FY2021FY2019FY2018FY2017FY2017
Revenue$2.9B$2.8B$2.8B$3.3B$3.8B$3.8B$2.9B$2.8B$2.3B$2.1B
Gross profit$2.0B$2.4B$2.1B$1.4B$1.3B$1.1B$1.0B
R&D expense$215.8M$196.8M$216.6M$221.6M$200.3M$146.4M$189.3M$194.0M$139.5M$124.2M
SG&A expense$991.9M$994.1M$1.0B$1.0B$975.2M$716.5M$815.3M$811.9M$626.0M$590.5M
Operating income$356.6M$346.7M$300.6M$742.7M$1.3B$867.3M$362.0M$323.9M$295.6M$294.6M
Interest expense$49.7M$63.6M$67.0M$43.9M$41.5M
Income tax$28.4M$33.1M$3.5M$139.2M$314.1M$169.5M$9.4M$20.2M$139.8M$28.4M
Net income$241.2M$270.4M$693.1M$569.2M$943.2M$727.9M$227.6M$237.9M$292.6M$234.3M
EPS (diluted)$2.07$2.20$5.55$4.50$8.08$6.49$2.04$2.13$2.64$2.12
Operating cash flow$589.0M$665.0M$279.4M$679.8M$1.4B$892.2M$363.5M$311.2M$292.2M$350.6M
Free cash flow$515.4M$578.3M$198.0M$594.2M$1.3B$828.5M$287.1M$218.0M$253.1M$318.9M
Cash & equivalents$919.9M$1.2B$913.2M$454.4M$603.3M$387.1M$191.9M$163.1M$202.1M$359.3M
Inventory$379.5M$367.6M$428.1M$405.5M$425.9M$514.6M$356.9M$338.3M$351.7M$246.8M
Total assets$12.2B$12.4B$13.6B$14.1B$15.0B$8.0B$6.5B$6.0B$6.1B$4.3B
Total liabilities$4.9B$4.7B$5.7B$6.7B$7.9B$4.2B$3.7B$3.4B$3.6B$2.1B
Shareholders' equity$7.3B$7.7B$7.9B$7.4B$7.1B$3.7B$2.8B$2.6B$2.5B$2.2B

Growth · year-over-year · Revenue CAGR 3.4%

MetricFY2025FY2024FY2023FY2023FY2022FY2021FY2019FY2018FY2017FY2017
Revenue growth+3.7%+0.2%-16.9%-13.5%+1.2%+31.2%+3.8%+23.1%+6.7%-6.5%
Net income growth-10.8%-61.0%+21.8%-39.7%+29.6%+219.9%-4.4%-18.7%+24.9%+10.3%
EPS growth-5.9%-60.4%+23.3%-44.3%+24.5%+218.1%-4.2%-19.3%+24.5%+13.4%
Free cash flow growth-10.9%+192.0%-66.7%-55.1%+59.9%+188.6%+31.7%-13.9%-20.6%+23.2%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-28. Facts plus Stocktoria's own computed scores — not investment advice.